Saad Albogami, Wael Alqarawi, Ahmed Alfagih, Hiatham Alenzi, Mohammad Alshehri, Mossab Aljuaid, Saeed Alqahtani, Norah Alswaidan, Mohammad Alharbi, Norah Alkaltham, Lama Alasmri, Rghd Sadkh, Muna Albashari, Nour Aljumaa, Imad Tleyjeh
{"title":"Cardiac Implantable Electronic Device Infections in Saudi Arabia: Incidence, Timing, Causative Organisms, and Outcomes - A Multicenter Study.","authors":"Saad Albogami, Wael Alqarawi, Ahmed Alfagih, Hiatham Alenzi, Mohammad Alshehri, Mossab Aljuaid, Saeed Alqahtani, Norah Alswaidan, Mohammad Alharbi, Norah Alkaltham, Lama Alasmri, Rghd Sadkh, Muna Albashari, Nour Aljumaa, Imad Tleyjeh","doi":"10.37616/2212-5043.1468","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiac implantable electronic devices (CIEDs) substantially improve outcomes in cardiac patients, but device-related infection can negate these benefits. Data on the epidemiology of CIED infections in Saudi Arabia are limited.</p><p><strong>Methods: </strong>We performed a multicenter retrospective cohort study of consecutive patients receiving CIEDs (pacemakers [PPM], implantable cardioverter-defibrillators [ICD], and cardiac resynchronization devices [CRT]) at three tertiary hospitals in Riyadh, Saudi Arabia, from January 2017 through December 2021. Patients were followed for at least one year post-implantation. Data collected included patient demographics, device type (new implant, replacement, revision), infection timing and microbiology, management (device extraction vs conservative treatment), and outcomes.</p><p><strong>Results: </strong>Of 4080 CIED recipients, 114 (2.8 %) developed device infections (incidence 98.8 per 10,000 person-years). CRT-P (cardiac resynchronization therapy pacemaker) devices had the highest infection rate (7.7 %). Revision procedures carried higher infection rates than initial implants or generator replacements (10.0 % vs 2.1 % vs 2.7 %; P < 0.001). The most common pathogens were <i>Staphylococcus aureus</i> (30.1 %), coagulase-negative staphylococci (10.6 %), and <i>Pseudomonas aeruginosa</i> (8.8 %); 38.9 % of infections were culture-negative. Systemic infections and patients managed without device removal had significantly higher mortality (32.3 % vs 8.2 % for systemic vs pocket; 48.4 % vs 12.0 % for no extraction vs extraction; P < 0.001 for both).</p><p><strong>Conclusions: </strong>In this large Saudi cohort, CIED infection occurred in 2.8 % of patients, particularly following revision procedures and in CRT-P recipients. Infections were often culture-negative and associated with substantial mortality, especially in systemic cases or when devices were not removed. These findings highlight the importance of strict infection-prevention protocols, early recognition, and prompt complete device extraction to improve patient outcomes.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"37 4","pages":"20"},"PeriodicalIF":1.4000,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12948620/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Saudi Heart Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37616/2212-5043.1468","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Cardiac implantable electronic devices (CIEDs) substantially improve outcomes in cardiac patients, but device-related infection can negate these benefits. Data on the epidemiology of CIED infections in Saudi Arabia are limited.
Methods: We performed a multicenter retrospective cohort study of consecutive patients receiving CIEDs (pacemakers [PPM], implantable cardioverter-defibrillators [ICD], and cardiac resynchronization devices [CRT]) at three tertiary hospitals in Riyadh, Saudi Arabia, from January 2017 through December 2021. Patients were followed for at least one year post-implantation. Data collected included patient demographics, device type (new implant, replacement, revision), infection timing and microbiology, management (device extraction vs conservative treatment), and outcomes.
Results: Of 4080 CIED recipients, 114 (2.8 %) developed device infections (incidence 98.8 per 10,000 person-years). CRT-P (cardiac resynchronization therapy pacemaker) devices had the highest infection rate (7.7 %). Revision procedures carried higher infection rates than initial implants or generator replacements (10.0 % vs 2.1 % vs 2.7 %; P < 0.001). The most common pathogens were Staphylococcus aureus (30.1 %), coagulase-negative staphylococci (10.6 %), and Pseudomonas aeruginosa (8.8 %); 38.9 % of infections were culture-negative. Systemic infections and patients managed without device removal had significantly higher mortality (32.3 % vs 8.2 % for systemic vs pocket; 48.4 % vs 12.0 % for no extraction vs extraction; P < 0.001 for both).
Conclusions: In this large Saudi cohort, CIED infection occurred in 2.8 % of patients, particularly following revision procedures and in CRT-P recipients. Infections were often culture-negative and associated with substantial mortality, especially in systemic cases or when devices were not removed. These findings highlight the importance of strict infection-prevention protocols, early recognition, and prompt complete device extraction to improve patient outcomes.
背景:心脏植入式电子装置(CIEDs)大大改善了心脏病患者的预后,但与装置相关的感染会抵消这些益处。沙特阿拉伯CIED感染的流行病学数据有限。方法:我们对2017年1月至2021年12月在沙特阿拉伯利雅得的三家三级医院连续接受cied(起搏器[PPM]、植入式心律转复除颤器[ICD]和心脏再同步装置[CRT])的患者进行了一项多中心回顾性队列研究。患者在植入后至少随访一年。收集的数据包括患者人口统计、器械类型(新植入物、置换、翻修)、感染时间和微生物学、管理(器械拔出vs保守治疗)和结果。结果:在4080名CIED受者中,114人(2.8%)发生器械感染(发病率为98.8 / 10000人年)。CRT-P(心脏再同步化治疗起搏器)装置的感染率最高(7.7%)。翻修手术的感染率高于初始植入物或发生器更换(10.0% vs 2.1% vs 2.7%; P < 0.001)。最常见的病原菌为金黄色葡萄球菌(30.1%)、凝固酶阴性葡萄球菌(10.6%)和铜绿假单胞菌(8.8%);38.9%的感染者培养阴性。全身性感染和未取出装置的患者死亡率明显更高(全身组32.3% vs袋式组8.2%;无拔牙组48.4% vs 12.0%;两者的P < 0.001)。结论:在这个庞大的沙特队列中,2.8%的患者发生了CIED感染,特别是在翻修手术后和CRT-P接受者中。感染通常为培养阴性,并与大量死亡率相关,特别是在全身性病例或未移除装置时。这些发现强调了严格的感染预防方案、早期识别和及时取出完整装置对改善患者预后的重要性。